5-fluorodopamine has been researched along with fluorodeoxyglucose f18 in 9 studies
| Studies (5-fluorodopamine) | Trials (5-fluorodopamine) | Recent Studies (post-2010) (5-fluorodopamine) | Studies (fluorodeoxyglucose f18) | Trials (fluorodeoxyglucose f18) | Recent Studies (post-2010) (fluorodeoxyglucose f18) |
|---|---|---|---|---|---|
| 76 | 8 | 16 | 34,771 | 2,160 | 20,111 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snow, BJ | 1 |
| Ayala, A; Carrasquillo, JA; Chen, CC; Del Corral, P; Ilias, I; Mamede, M; Pacak, K; Whatley, M | 1 |
| Carrasquillo, JA; Chen, CC; Hadi, M; Pacak, K; Whatley, M | 1 |
| de Beco, V; Le Bars, D; Scherrmann, JM | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| Karges, W; Mottaghy, FM; Van Binnebeek, S | 1 |
| Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC | 1 |
| Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
| Blanchet, EM; Bluemke, DA; Maass-Moreno, R; Martucci, V; Millo, C; Pacak, K | 1 |
2 review(s) available for 5-fluorodopamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Positron emission tomography in Parkinson's disease.
Topics: Deoxyglucose; Dopamine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Tomography, Emission-Computed | 1992 |
[Fluorine-18 in radiopharmacy].
Topics: Animals; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
2 trial(s) available for 5-fluorodopamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult | 2011 |
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; National Institutes of Health (U.S.); Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2014 |
5 other study(ies) available for 5-fluorodopamine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dopamine; Epinephrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2007 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Functional imaging of neuroendocrine tumors.
Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin | 2011 |
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |